MindMate: A Study of a Reminder System for People With Dementia

Dementia Clinical Trial

Official title:

MindMate: A Single Case Experimental Design Study of a Reminder System for People With Mild Dementia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02908997
• Other study ID #: GN16NE538
• Status: Completed
• Phase: N/A
• Start date: January 17, 2017
• Est. completion date: July 31, 2018

Study information

• Verified date: November 2018
• Source: NHS Greater Glasgow and Clyde
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia

Description:

Background

Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.

Aims

This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.

Method

Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.

Applications

This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3
• Est. completion date: July 31, 2018
• Est. primary completion date: July 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• has a diagnosis of Mild Dementia, according to International Classification of Diseases (ICD) 10 Criteria

• has received the diagnosis from a psychiatrist

• owns a smart phone or tablet

• has a family member/partner/carer who is willing to monitor memory aid use

• has capacity to consent to being involved in the research

• is reporting memory difficulties that are affecting them in daily life

Exclusion Criteria:

• visual or auditory difficulties which cannot be corrected through the use of appropriate aids

• has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)

• has a diagnosis of dementia that is considered to be in the moderate to severe stages

• those whose first language is not English

• those with a diagnosed or suspected developmental learning disability

• those who are currently using online or electronic memory aids

Related Conditions & MeSH terms

• Dementia

Intervention

Other:
• MindMate
A dementia-specific mobile reminding application

Locations

Country	Name	City	State
United Kingdom	NHS Greater Glasgow and Clyde	Glasgow

Sponsors (2)

Lead Sponsor	Collaborator
NHS Greater Glasgow and Clyde	University of Glasgow

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Memory	Number of target events the participant remembered to complete	6 weeks
Secondary	Acceptability	Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire	Change from baseline to 6 week post-intervention